We are live on
!
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter
Est. Return
-12.75%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$258M
AUM Growth
-$43.5M
(-14%)
Cap. Flow
+$1.68M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
39.65%
Holding
62
New
5
Increased
16
Reduced
5
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.65M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$5.9M |
| 3 |
Tesla
TSLA
|
+$2.56M |
| 4 |
Becton Dickinson
BDX
|
+$2.53M |
| 5 |
Abbott
ABT
|
+$2.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$7.51M |
| 2 |
Broadcom
AVGO
|
+$5.79M |
| 3 |
IPG Photonics
IPGP
|
+$5.23M |
| 4 |
American Eagle Outfitters
AEO
|
+$1.99M |
| 5 |
Pfizer
PFE
|
+$1.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.59% |
| 2 | Technology | 19.47% |
| 3 | Industrials | 15% |
| 4 | Communication Services | 10.95% |
| 5 | Consumer Discretionary | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Novartis
NVS
$289B
| $768K | 0.3% |
9,315
| – | – |
|
|
WIRE
52
DELISTED
Encore Wire Corp
WIRE
| $546K | 0.21% |
13,000
| – | – |
|
53
GE Aerospace
GE
$355B
| $391K | 0.15% |
9,891
-28,089
| -74% | -$1.5M |
|
|
CDK
54
DELISTED
CDK Global, Inc.
CDK
| $356K | 0.14% |
10,833
| – | – |
|
|
55
American Eagle Outfitters
AEO
$2.91B
| – | – |
-135,460
| Closed | -$1.99M |
|
|
56
Broadcom
AVGO
$1.82T
| – | – |
-183,350
| Closed | -$5.79M |
|
|
57
Boston Scientific
BSX
$65.6B
| – | – |
-166,015
| Closed | -$7.51M |
|
58
Corteva
CTVA
$58.5B
| – | – |
-8,546
| Closed | -$253K |
|
59
DuPont de Nemours
DD
$18.5B
| – | – |
-6,808
| Closed | -$549K |
|
60
Dow Inc
DOW
$21.9B
| – | – |
-8,546
| Closed | -$468K |
|
|
61
IPG Photonics
IPGP
$4.21B
| – | – |
-36,090
| Closed | -$5.23M |
|
62
J.M. Smucker
SJM
$12B
| – | – |
-2,125
| Closed | -$221K |
|
Similar funds
RC
TTSTC
KFAS
RIS
AMG
BWP
MC
ACP
Chad R. Baker's Q1 2020 Portfolio in Review
As of Q1 2020, Chad R. Baker held 62 positions worth $258M, down 14% from $301M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Chad R. Baker's Q1 2020 filing shows 5 new, 16 increased, 5 reduced and 8 closed positions. Its largest new stake was Microsoft: 52,625 shares worth $8.3M. The largest sale was Boston Scientific, an estimated $7.51M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.
- Chad R. Baker's largest Q1 2020 buy was Microsoft: 52,625 shares worth $8.3M.
- Chad R. Baker added most to Abbott in Q1 2020, an estimated $2.39M increase.
- Chad R. Baker's biggest Q1 2020 reduction was Pfizer, cutting an estimated $1.69M.
- Chad R. Baker fully exited Boston Scientific in Q1 2020, selling an estimated $7.51M.
- Chad R. Baker's ten largest holdings make up 40% of its $258M portfolio in Q1 2020.
- Chad R. Baker opened 5 new positions and closed 8 in Q1 2020.
- Chad R. Baker's portfolio value fell 14% quarter-over-quarter to $258M.
Based on Chad R. Baker's 13F filing for Q1 2020, filed 1 May 2020.